Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

A First-Hand Look at India's Pharma Services Sector

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
Mar 2, 2011

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.

What to Watch for in 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Feb 2, 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

The Preferred-Provider Model

The designation of preferred partners has become integral to the outsourcing process. Read this and other preferred organization articles in this special issue.
Feb 1, 2011

The designation of preferred partners has become integral to the outsourcing process. Read this and other preferred organization articles in this special issue.

Winning Big

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.
Jan 5, 2011

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.

What to Watch for in 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Jan 2, 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

Winning Big

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.
Dec 2, 2010

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.

Buyers in Short Supply

Global pharmaceutical companies could have a problem getting rid of redundant facilities.
Nov 5, 2010

Global pharmaceutical companies could have a problem getting rid of redundant facilities.

R&D Mash-ups

Changing demands in drug development lead to new service combinations and models.
Oct 12, 2010

Changing demands in drug development lead to new service combinations and models.

Buyers in Short Supply

Global pharmaceutical companies could have a problem getting rid of redundant facilities.
Oct 2, 2010

Global pharmaceutical companies could have a problem getting rid of redundant facilities.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here